NASDAQ$NOTV
Inotiv Inc · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Inotiv's Q4 fiscal year 2020 earnings were released, showing an increase in revenue but a net loss due to increased costs and investments in infrastructure.
Inotiv reported a 6.7% increase in revenue for the fourth quarter of fiscal year 2020, primarily driven by the PCRS acquisition. However, the company experienced a net loss due to increased costs associated with capacity expansion, infrastructure development, and general administrative expenses.
- Revenue increased by 6.7% compared to the fourth quarter of fiscal 2019, reaching $15.774 million.
- Service revenue increased by 11.1%, driven by nonclinical services revenues and the PCRS acquisition.
- Net loss amounted to $1.792 million, or $0.16 per diluted share, compared to net income of $290,000, or $0.03 per diluted share in Q4 2019.
- The company's book-to-bill ratio for the quarter was 1.48x, and the backlog at the end of the quarter was $43.8 million.
Headline financials
Revenue & EPS history
Inotiv · Revenue · Quarterly
$15.8M
Revenue by segment
Inotiv · $158M total across 2 segments · Q3 2023
- RMS$111M-17.5%70.3%
- DSA$46.8M-2.3%29.7%
Forward guidance
Inotiv anticipates continued internal growth by adding services and expanding capacity, along with exploring selective external growth opportunities to broaden its platform and drive shareholder value. The company intends to enhance client experience, build a winning culture, and create a gratifying work environment, while also updating governance practices and proposing a formal corporate name change to Inotiv, Inc.
Tailwinds
- Focus on internal growth by adding services and expanding capacity.
- Explore selective external growth opportunities to add breadth and value.
- Commitment to enhancing client experience and building a winning culture.
- Aim to create a professionally gratifying work environment.
- Intention to update governance practices.
Headwinds
- The pandemic had a negative impact on financial results.
- Experienced customer delays or pauses of studies.
- Pandemic-related impacts on employees, suppliers, and clients.
- Decreasing margins as fixed costs increased to support anticipated future growth.
- Developing unutilized capacity in the fourth quarter.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q4 2020
+0.4%
Avg return
Earnings day
+3.5%
Avg return
5 days after
+5.6%
Avg return
30 days after
39%
25 / 64 earnings
Positive
+51.3%
Q4 2022
Best reaction
-35.7%
Q3 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2026 | -3.6% | -0.2% | -72.5% | |
| Q1 2026 | -14.3% | -33.3% | -7.1% | |
| Q4 2025 | -6.3% | -9.6% | -42.6% | |
| Q2 2025 | +11.2% | +4.5% | +33.8% | |
| Q1 2025 | -12.9% | -8.9% | -41.8% | |
| Q4 2024 | +0.8% | -2.6% | +7.4% | |
| Q3 2024 | +5.0% | -5.0% | -15.7% | |
| Q2 2024 | +0.9% | -13.2% | -17.0% | |
| Q1 2024 | +15.0% | +45.5% | +126.5% | |
| Q4 2023 | -24.6% | -7.1% | +17.2% | |
| Q3 2023 | -35.7% | -40.7% | -49.0% | |
| Q2 2023 | -7.0% | +0.2% | -13.1% | |
| Q1 2023 | +4.5% | +4.4% | -30.1% | |
| Q4 2022 | +51.3% | +67.4% | +47.4% | |
| Q3 2022 | +24.9% | +33.9% | +16.1% | |
| Q2 2022 | +42.5% | +60.3% | +21.1% | |
| Q1 2022 | -18.7% | -28.8% | -47.9% | |
| Q4 2021 | -13.0% | +9.7% | -19.8% | |
| Q3 2021 | +6.5% | +3.2% | +13.1% | |
| Q2 2021 | +4.2% | +9.3% | +9.6% | |
| Q1 2021 | +25.2% | +34.7% | +48.4% | |
| Q4 2020 | +20.9% | +13.6% | +74.3% | |
| Q3 2020 | -12.8% | -15.7% | -10.6% | |
| Q2 2020 | +6.2% | +13.2% | +25.4% | |
| Q1 2020 | -12.3% | -13.1% | -20.4% | |
| Q4 2019 | +13.7% | +10.8% | +34.5% | |
| Q3 2019 | -4.8% | +16.2% | +73.8% | |
| Q2 2019 | -2.9% | -4.8% | -4.3% | |
| Q1 2019 | -4.9% | -2.1% | +31.9% | |
| Q4 2018 | -2.3% | -2.3% | +6.8% | |
| Q3 2018 | +0.0% | +6.7% | +7.3% | |
| Q2 2018 | +0.6% | -2.3% | -5.2% | |
| Q1 2018 | -19.6% | -16.4% | -15.3% | |
| Q4 2017 | -3.9% | -5.7% | -22.1% | |
| Q3 2017 | -4.0% | -2.8% | -9.7% | |
| Q2 2017 | +6.3% | +3.2% | +5.7% | |
| Q1 2017 | +23.1% | +20.9% | +64.8% | |
| Q4 2016 | +10.0% | -1.2% | +17.5% | |
| Q3 2016 | -13.6% | -4.3% | -18.6% | |
| Q2 2016 | -6.9% | — | — | |
| Q1 2016 | -14.3% | — | — | |
| Q4 2015 | -3.1% | — | — | |
| Q3 2015 | -8.6% | — | — | |
| Q2 2015 | -1.9% | — | — | |
| Q1 2015 | -5.5% | — | — | |
| Q4 2014 | -7.5% | — | — | |
| Q3 2014 | +15.2% | — | — | |
| Q2 2014 | -2.3% | — | — | |
| Q1 2014 | -9.8% | — | — | |
| Q4 2013 | +9.6% | — | — | |
| Q3 2013 | +25.9% | — | — | |
| Q2 2013 | +9.6% | — | — | |
| Q1 2013 | +3.4% | — | — | |
| Q4 2012 | -5.9% | — | — | |
| Q3 2012 | +4.8% | — | — | |
| Q2 2012 | -7.5% | — | — | |
| Q1 2012 | +0.0% | — | — | |
| Q1 2011 | +0.0% | — | — | |
| Q4 2011 | -3.8% | — | — | |
| Q2 2011 | -3.8% | — | — | |
| Q4 2010 | -4.3% | — | — | |
| Q3 2011 | -4.3% | — | — | |
| Q3 2010 | -4.3% | — | — | |
| Q2 2010 | -3.2% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro